glp-1/gip receptor agonist GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Polyagonists Enable Increasingly Effective Treatment

The drugs initially were developed to treat diabetes, before their weight loss benefits were observed

( d ) Coomassie-stained, reducing SDS-PAGE gel

Besides promoting weight loss and helping avoid overeating, GLP-1 medications may also offer the following benefits: Improves cardiovascular health: Several GLP-1 agonists may be effective in reducing the risk of cardiovascular disease in people with type 2 diabetes

Not all patients qualify

S.et al (2014)

A 2024 scoping review by Karacabeyli and Lacaille found GLP-1 medications inhibit the NF-kB pathway one of the bodys master inflammation switches in RA and psoriasis cell models, even before weight changes